JP2025181917A5 - - Google Patents
Info
- Publication number
- JP2025181917A5 JP2025181917A5 JP2025156043A JP2025156043A JP2025181917A5 JP 2025181917 A5 JP2025181917 A5 JP 2025181917A5 JP 2025156043 A JP2025156043 A JP 2025156043A JP 2025156043 A JP2025156043 A JP 2025156043A JP 2025181917 A5 JP2025181917 A5 JP 2025181917A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variable domain
- chain variable
- histidine
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962910935P | 2019-10-04 | 2019-10-04 | |
| US62/910,935 | 2019-10-04 | ||
| PCT/US2020/053910 WO2021067673A1 (en) | 2019-10-04 | 2020-10-02 | Antigen-binding protein constructs and uses thereof |
| JP2022520676A JP7818509B2 (ja) | 2019-10-04 | 2020-10-02 | 抗原結合タンパク質構築物およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520676A Division JP7818509B2 (ja) | 2019-10-04 | 2020-10-02 | 抗原結合タンパク質構築物およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025181917A JP2025181917A (ja) | 2025-12-11 |
| JP2025181917A5 true JP2025181917A5 (https=) | 2026-03-02 |
Family
ID=73014627
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520676A Active JP7818509B2 (ja) | 2019-10-04 | 2020-10-02 | 抗原結合タンパク質構築物およびその使用 |
| JP2025156043A Pending JP2025181917A (ja) | 2019-10-04 | 2025-09-19 | 抗原結合タンパク質構築物およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520676A Active JP7818509B2 (ja) | 2019-10-04 | 2020-10-02 | 抗原結合タンパク質構築物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220348679A1 (https=) |
| EP (1) | EP4037775A1 (https=) |
| JP (2) | JP7818509B2 (https=) |
| CN (2) | CN114728175A (https=) |
| AU (1) | AU2020357980A1 (https=) |
| CA (1) | CA3157028A1 (https=) |
| IL (1) | IL291904A (https=) |
| WO (1) | WO2021067673A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050239700A1 (en) * | 2003-10-14 | 2005-10-27 | Biogen Idec Inc. | Treatment of cancer using antibodies to LRRC15 |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| CN102149825B (zh) | 2008-07-08 | 2015-07-22 | Abbvie公司 | 前列腺素e2双重可变结构域免疫球蛋白及其用途 |
| WO2011028811A2 (en) | 2009-09-01 | 2011-03-10 | Abbott Laboratories | Dual variable domain immunoglobulins and uses thereof |
| BR112012008833A2 (pt) | 2009-10-15 | 2015-09-08 | Abbott Lab | imunoglobulinas de dominio variavel duplo e usos das mesmas |
| UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| JP5932670B2 (ja) * | 2010-03-11 | 2016-06-08 | ライナット ニューロサイエンス コーポレイション | ｐＨ依存性の抗原結合を有する抗体 |
| TWI667257B (zh) * | 2010-03-30 | 2019-08-01 | 中外製藥股份有限公司 | 促進抗原消失之具有經修飾的ＦｃＲｎ親和力之抗體 |
| EP3252072A3 (en) | 2010-08-03 | 2018-03-14 | AbbVie Inc. | Dual variable domain immunoglobulins and uses thereof |
| AU2016365117A1 (en) | 2015-11-30 | 2018-05-31 | Abbvie Biotherapeutics Inc. | Anti-huLRRC15 antibody drug conjugates and methods for their use |
| AU2016365114A1 (en) * | 2015-11-30 | 2018-05-17 | Abbvie Biotherapeutics Inc. | Anti-huLRRC15 antibody drug conjugates and methods for their use |
| WO2019075392A1 (en) * | 2017-10-12 | 2019-04-18 | Inevation Llc | ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF |
-
2020
- 2020-10-02 EP EP20797282.9A patent/EP4037775A1/en active Pending
- 2020-10-02 US US17/765,153 patent/US20220348679A1/en active Pending
- 2020-10-02 AU AU2020357980A patent/AU2020357980A1/en active Pending
- 2020-10-02 CA CA3157028A patent/CA3157028A1/en active Pending
- 2020-10-02 CN CN202080081551.9A patent/CN114728175A/zh active Pending
- 2020-10-02 WO PCT/US2020/053910 patent/WO2021067673A1/en not_active Ceased
- 2020-10-02 JP JP2022520676A patent/JP7818509B2/ja active Active
- 2020-10-02 CN CN202510265904.5A patent/CN120204419A/zh active Pending
-
2022
- 2022-04-03 IL IL291904A patent/IL291904A/en unknown
-
2025
- 2025-09-19 JP JP2025156043A patent/JP2025181917A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531826A (ja) | 栄養膜細胞表面抗原２（ｔｒｏｐ２）に対する特異的な抗体 | |
| JP6317674B2 (ja) | 医学的使用のための二重特異性抗体 | |
| JP2022543771A5 (https=) | ||
| JP2025181917A5 (https=) | ||
| TW202019472A (zh) | 葉酸受體阿法特異性抗體 | |
| TW202302650A (zh) | 針對dll3的結合分子及其應用 | |
| WO2023151613A1 (zh) | 一种双特异性抗原结合分子及其应用 | |
| JP2022535452A5 (https=) | ||
| CN108025093A (zh) | 用于在治疗癌症中使用的放射性标记的抗体片段 | |
| RU2013134983A (ru) | Рекомбинантные антитела против фактора роста эндотелия сосудов (vegf), полученные посредством мутагенеза вариабельной области | |
| TW202302651A (zh) | 一種雙抗組合及其應用 | |
| TW202115121A (zh) | 抗ｐｄ－ｌ１抗體及其應用 | |
| CN106164094A (zh) | 双特异性抗原结合多肽 | |
| JP2022534808A5 (https=) | ||
| CN107474139A (zh) | 一种靶向人肿瘤干细胞的单克隆抗体及其应用 | |
| US20240059764A1 (en) | ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF | |
| JP2022502079A5 (https=) | ||
| JP2022514477A5 (https=) | ||
| CN115348971A (zh) | 抗体-药物缀合物 | |
| TW202207993A (zh) | 位點特異性her2抗體-藥物共軛物之治療 | |
| WO2021244371A1 (zh) | 一种抗pd-l1/vegf融合蛋白 | |
| CN103417965B (zh) | 一种含有抗vegf抗体的药物组合物 | |
| WO2018233333A9 (zh) | 一种靶向人肿瘤干细胞的单克隆抗体及其应用 | |
| JP2025503176A5 (https=) | ||
| CN107163146A (zh) | 一种靶向人肿瘤干细胞的单克隆抗体及其应用 |